1. WHO (2001) Epilepsy: aetiology, epidemiology and prognosis. Fact sheet No. 165
2. Urbanska EM, Czuczwar SJ, Kleinrok Z, Turski WA (1998) Excitatory amino acids in epilepsy. Restor Neurol Neurosci 13:25–39
3. Lode H, Borner K, Koeppe P (1998) Pharmacodynamics of fluoroquinolones. Clin Infect Dis 27:33–39
4. Petri WA (2011) Sulfonamides, trimethoprim-sulfomethoxazole, quinolones and agents for urinary tract infections. In: Brunton LL (ed) Goodmans and Gilman’s the pharmacological basis of therapeutics, 12th edn. The MaGraw-Hill Companies Inc., New York, pp 1463–1476
5. Marians KJ, Hiasa H (1997) Mechanism of quinolone action. A druginduced structural perturbation of the DNA precedes strand cleavage by topoisomerase IV. J Biol Chem 272:9401–9409